Want to know what the ACO has been up to?
The Annual Report offers highlights of ACO activities over the past fiscal year.
Read our 2015-2016 Annual Update
Advancing HIV Vaccines
Enabling productive interactions that foster new thinking and research capacity to accelerate the development of an HIV vaccine. Read more
Canadian Research that Stands Out
Facilitating an innovative and robust Canadian contribution to global HIV vaccine efforts. Read more
Building Networks Across Borders
Capitalizing on Canada’s strengths and creating new opportunities for international collaboration. Read more
HIVR4P Satellite Session: Beyond Viral Neutralization
Friday, October 21, 2016 | Chicago
The main aim of this satellite session is to bring the scientific community together to discuss the latest developments in the expanding field of non-neutralizing, effector function competent (nNeFC) anti-HIV-1 antibodies.
This satellite session will be hosted and facilitated by the ACO.
Researcher in Focus: Felicien Moukambi
The ACO continues to feature Canadian researchers who are making an impact in HIV vaccine research and development. At the CAHR Conference held in Winnipeg, Manitoba (May 2016), HIV researcher Felicién Moukambi, talked to us about his research on the depletion of Tfh cells in SIV-infected macaques. Felicién works at the laboratory of Dr. Jérôme Estaquier at the Centre de recherche du CHU de Québec.